Ryotaro Iwasaki

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Prognosis of medication-related osteonecrosis of the jaw based on the immunonutritional biomarker.

Prognosis of medication-related osteonecrosis of the jaw based on the immunonutritional biomarker.

Journal: Oral surgery, oral medicine, oral pathology and oral radiology

Published: September 27, 2025

DC-STAMP and OC-STAMP cooperatively regulate osteoclast and foreign body giant cell cell-cell fusion.

DC-STAMP and OC-STAMP cooperatively regulate osteoclast and foreign body giant cell cell-cell fusion.

Journal: Journal of bone and mineral metabolism

Published: July 11, 2025

Factors affecting the quality of life of patients with medication-related osteonecrosis of the jaw during treatment: A quality-of-life survey and causal analysis.

Factors affecting the quality of life of patients with medication-related osteonecrosis of the jaw during treatment: A quality-of-life survey and causal analysis.

Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery

Published: January 23, 2024

An ionic silver coating prevents implant-associated infection by anaerobic bacteria in vitro and in vivo in mice.

An ionic silver coating prevents implant-associated infection by anaerobic bacteria in vitro and in vivo in mice.

Journal: Scientific reports

Published: April 27, 2022

Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics.

Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics.

Journal: Scientific reports

Published: August 03, 2021

Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw.

Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw.

Journal: Journal of bone and mineral metabolism

Published: May 06, 2020

Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis.

Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis.

Journal: Scientific reports

Published: January 18, 2017

Selective Estrogen Receptor Modulators Suppress Hif1α Protein Accumulation in Mouse Osteoclasts.

Selective Estrogen Receptor Modulators Suppress Hif1α Protein Accumulation in Mouse Osteoclasts.

Journal: PloS one

Published: August 09, 2016

Smad4 is required to inhibit osteoclastogenesis and maintain bone mass.

Smad4 is required to inhibit osteoclastogenesis and maintain bone mass.

Journal: Scientific reports

Published: June 07, 2016

Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab.

Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab.

Journal: Journal of prosthodontic research

Published: July 18, 2014

TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state.

TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state.

Journal: Oncogene

Published: October 29, 2013

An essential role for STAT6-STAT1 protein signaling in promoting macrophage cell-cell fusion.

An essential role for STAT6-STAT1 protein signaling in promoting macrophage cell-cell fusion.

Journal: The Journal of biological chemistry

Published: August 07, 2012

Showing 1-12 of 16

Last Updated: 09/26/2026